Bank Julius Baer & Co. Ltd, Zurich Arcturus Therapeutics Holdings Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

$27 Billion
Q1 2025

A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 2,035 shares of ARCT stock, worth $24,257. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,035

Previous 2,084 2.35%

Holding current value

$24,257

Previous $35,000 40.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 06, 2025	SELL	$10.59 - $20.83 $518 - $1,020	-49 Reduced 2.35%	2,035 $21,000
Q4 2024 Feb 07, 2025	SELL	$14.82 - $25.48 $343,838 - $591,161	-23,201 Reduced 91.76%	2,084 $35,000
Q3 2024 Nov 14, 2024	SELL	$18.08 - $25.38 $35,635 - $50,023	-1,971 Reduced 7.23%	25,285 $586,000
Q2 2024 Aug 14, 2024	SELL	$24.35 - $44.39 $401,921 - $732,701	-16,506 Reduced 37.72%	27,256 $663,000
Q1 2024 May 14, 2024	SELL	$31.23 - $42.99 $108,368 - $149,175	-3,470 Reduced 7.35%	43,762 $1.48 Million
Q4 2023 May 16, 2024	BUY	$17.71 - $32.97 $61,453 - $114,405	3,470 Added 7.93%	47,232 $1.49 Million
Q4 2023 Feb 02, 2024	SELL	$17.71 - $32.97 $195,305 - $363,593	-11,028 Reduced 18.93%	47,232 $1.49 Million
Q3 2023 Nov 13, 2023	SELL	$25.44 - $37.35 $39,915 - $58,602	-1,569 Reduced 2.62%	58,260 $1.49 Million
Q2 2023 Jul 24, 2023	BUY	$23.94 - $32.36 $1.43 Million - $1.94 Million	59,829 New	59,829 $1.72 Million
Q1 2023 May 11, 2023	BUY	$14.72 - $23.97 $55,141 - $89,791	3,746 Added 5.65%	70,070 $1.68 Million
Q4 2022 Jan 24, 2023	BUY	$14.14 - $23.06 $94,836 - $154,663	6,707 Added 11.25%	66,324 $1.13 Million
Q3 2022 Nov 04, 2022	SELL	$13.05 - $22.13 $851,134 - $1.44 Million	-65,221 Reduced 52.24%	59,617 $884,000
Q2 2022 Jul 22, 2022	SELL	$12.26 - $31.17 $1.13 Million - $2.88 Million	-92,425 Reduced 42.54%	124,838 $1.97 Million
Q1 2022 May 09, 2022	SELL	$17.64 - $39.57 $862,719 - $1.94 Million	-48,907 Reduced 18.37%	217,263 $5.86 Million
Q4 2021 Feb 15, 2022	SELL	$34.2 - $47.56 $14.2 Million - $19.7 Million	-414,079 Reduced 60.87%	266,170 $9.85 Million
Q3 2021 Nov 12, 2021	SELL	$27.88 - $58.25 $628,108 - $1.31 Million	-22,529 Reduced 3.21%	680,249 $32.5 Million
Q2 2021 Jul 23, 2021	BUY	$25.79 - $42.11 $7.41 Million - $12.1 Million	287,237 Added 69.12%	702,778 $23.8 Million
Q1 2021 May 10, 2021	BUY	$38.75 - $86.92 $3.08 Million - $6.91 Million	79,464 Added 23.64%	415,541 $17.2 Million
Q4 2020 Feb 24, 2021	SELL	$34.61 - $123.66 $6.83 Million - $24.4 Million	-197,254 Reduced 36.99%	336,077 $14.6 Million
Q4 2020 Feb 12, 2021	BUY	$34.61 - $123.66 $13.8 Million - $49.2 Million	398,063 Added 294.28%	533,331 $14.6 Million
Q3 2020 Nov 10, 2020	BUY	$37.49 - $63.19 $5.07 Million - $8.55 Million	135,268 New	135,268 $5.9 Million

Others Institutions Holding ARCT

# of Institutions

165

Shares Held

25.8M

Call Options Held

163K

Put Options Held

173K

View Full List

About Arcturus Therapeutics Holdings Inc.

Ticker ARCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,576,400
Market Cap $317M
Description
Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...

More about ARCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

News

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.

Account

Bank Julius Baer & Co. Ltd, Zurich Arcturus Therapeutics Holdings Inc. Transaction History